Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-guided fluorescence surgery in ovarian, fallopian tube, and peritoneal cancer
jRCTs031240345Completed
- Sponsor
- SBI Pharmaceuticals
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by SBI Pharmaceuticals. Primary endpoint: Sensitivity of photodynamic diagnosis on biopsy tissue specimens. Started Oct 2024; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on jRCTs031240345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240345.